Abstract

Sepsis refers to organ failure due to uncontrolled body immune responses towards infection. The systemic inflammatory response triggered by pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS) from Gram-negative bacteria, is accompanied by the release of various proinflammatory mediators that can lead to organ damage. The progression to septic shock is even more life-threatening due to hypotension. Thus, sepsis is a leading cause of death and morbidity globally. However, current therapies are mainly symptomatic treatment and rely on the use of antibiotics. The lack of a specific treatment demands exploration of new drugs. Malaysian herbal plants have a long history of usage for medicinal purposes. A total of 64 Malaysian plants commonly used in the herbal industry have been published in Malaysian Herbal Monograph 2015 and Globinmed website (http://www.globinmed.com/). An extensive bibliographic search in databases such as PubMed, ScienceDirect, and Scopus revealed that seven of these plants have antisepsis properties, as evidenced by the therapeutic effect of their extracts or isolated compounds against sepsis-associated inflammatory responses or conditions in in vitro or/and in vivo studies. These include Andrographis paniculata, Zingiber officinale, Curcuma longa, Piper nigrum, Syzygium aromaticum, Momordica charantia, and Centella asiatica. Among these, Z. officinale is the most widely studied plant and seems to have the highest potential for future therapeutic applications in sepsis. Although both extracts as well as active constituents from these herbal plants have demonstrated potential antisepsis activity, the activity might be primarily contributed by the active constituent(s) from each of these plants, which are andrographolide (A. paniculata), 6-gingerol and zingerone (Z. officinale), curcumin (C. longa), piperine and pellitorine (P. nigrum), biflorin (S. aromaticum), and asiaticoside, asiatic acid, and madecassoside (C. asiatica). These active constituents have shown great antisepsis effects, and further investigations into their clinical therapeutic potential may be worthwhile.

Highlights

  • Kong Yen Liew, Md Faizul Hafiz, Yi Joong Chong, Hanis Hazeera Harith, Daud Ahmad Israf, and Chau Ling Tham

  • Sepsis refers to organ failure due to uncontrolled body immune responses towards infection. e systemic inflammatory response triggered by pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS) from Gram-negative bacteria, is accompanied by the release of various proinflammatory mediators that can lead to organ damage. e progression to septic shock is even more life-threatening due to hypotension. us, sepsis is a leading cause of death and morbidity globally

  • Sepsis is a major cause of death and morbidity worldwide [8, 12]. e current approaches in managing sepsis patients include initial resuscitation, early diagnosis to allow prompt treatment using specific antibiotics, and identification of infection source and control measures [2]. ese have improved the outcomes of sepsis patients; the mortality rate remains unreasonably high [4]

Read more

Summary

Introduction

Kong Yen Liew , Md Faizul Hafiz , Yi Joong Chong , Hanis Hazeera Harith , Daud Ahmad Israf , and Chau Ling Tham. E exposure of immune cells to PAMPs, such as lipopolysaccharide (LPS), will trigger numerous responses in the body, including vasodilation to increase recruitment of immune cells, followed by rapid production of cytokines by activated immune cells to eradicate the invading pathogens [6]. While such cellular responses are required to remove the pathogens, the same responses could lead to profound disturbance and harm to the host. In essence, a form of “friendly fire” that arises from the body’s attempt to eradicate the pathogens

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call